National News
NAFDAC halts Artemether/Lumefantrine registration

The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
National News15 hours ago
Nigeria safe for investment, Edun tells Global Investors at IMF/World Bank Forum
-
FCT News1 day ago
NUJ FCT to honour Moji Danisa as Trailblazer in Tabloid Journalism
-
Journalism / Human Right2 days ago
NUJ condemns rising killings, demands urgent action from political, security leaders
-
News2 days ago
NAHCON, States fix May 9 for 2025 Hajj inaugural flight
-
FCT News1 day ago
FCT rolls out free holiday vocational training for women, youth
-
News15 hours ago
Wike fumes over exclusion of Julius Berger in Abuja Conference Centre contract
-
News2 days ago
Benue Judiciary Workers suspend strike after four Months
-
World News15 hours ago
ECOWAS Council of Ministers meets in Accra over withdrawal of Niger, Mali, Burkina Faso